These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1037366)

  • 1. Immunosuppressive drug therapy as a potentiator of skin tumours in five patients with lymphoma.
    Hill BH
    Australas J Dermatol; 1976 Aug; 17(2):46-8. PubMed ID: 1037366
    [No Abstract]   [Full Text] [Related]  

  • 2. [Puva therapy and carcinogenesis].
    Thomas P; Pannequin C
    Ann Dermatol Venereol; 1991; 118(6-7):503-6. PubMed ID: 1897842
    [No Abstract]   [Full Text] [Related]  

  • 3. Skin cancers and non-hodgkin lymphoma among users of systemic glucocorticoids: a population-based cohort study.
    Sørensen HT; Mellemkjaer L; Nielsen GL; Baron JA; Olsen JH; Karagas MR
    J Natl Cancer Inst; 2004 May; 96(9):709-11. PubMed ID: 15126608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iatrogenic immunosuppression and cutaneous malignancy.
    DePry JL; Reed KB; Cook-Norris RH; Brewer JD
    Clin Dermatol; 2011; 29(6):602-13. PubMed ID: 22014982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
    Falk S; Walther F; Denk R
    Hautarzt; 1996 Sep; 47(9):716-8. PubMed ID: 8999030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three cases of activation of cutaneous squamous-cell carcinoma during treatment with prolonged administration of rituximab.
    Fogarty GB; Bayne M; Bedford P; Bond R; Kannourakis G
    Clin Oncol (R Coll Radiol); 2006 Mar; 18(2):155-6. PubMed ID: 16523821
    [No Abstract]   [Full Text] [Related]  

  • 7. Skin tumours in immunosuppressed patients.
    Marshall VC
    Aust N Z J Surg; 1973 Dec; 43(3):214-22. PubMed ID: 4618104
    [No Abstract]   [Full Text] [Related]  

  • 8. The risk of malignancy associated with the use of biological agents in patients with inflammatory bowel disease.
    Dulai PS; Siegel CA
    Gastroenterol Clin North Am; 2014 Sep; 43(3):525-41. PubMed ID: 25110257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arsenic as a cause of skin cancer, with notes on its occurrence in Pretoria.
    Schulz EJ
    S Afr Med J; 1967 Sep; 41(33):819-22. PubMed ID: 6060318
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemical exposures other than arsenic are probably not important risk factors for squamous cell carcinoma, basal cell carcinoma and malignant melanoma of the skin.
    Kennedy C; Bajdik CD; Willemze R; Bouwes Bavinck JN
    Br J Dermatol; 2005 Jan; 152(1):194-7. PubMed ID: 15656837
    [No Abstract]   [Full Text] [Related]  

  • 11. Skin cancer and immunosuppression.
    Walder BK; Robertson MR; Jeremy D
    Lancet; 1971 Dec; 2(7737):1282-3. PubMed ID: 4143536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple actinic keratosis and skin tumors secondary to hydroxyurea treatment.
    Salmon-Ehr V; Grosieux C; Potron G; Kalis B
    Dermatology; 1998; 196(2):274. PubMed ID: 9568428
    [No Abstract]   [Full Text] [Related]  

  • 13. Accelerated growth of skin carcinoma following fludarabine therapy for chronic lymphocytic leukemia.
    Rashid K; Ng R; Mastan A; Sager D; Hirschman R
    Leuk Lymphoma; 2005 Jul; 46(7):1051-5. PubMed ID: 16019557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid arthritis, TNF inhibitors, and non-melanoma skin cancer.
    Assassi S
    BMJ; 2016 Jan; 352():i472. PubMed ID: 26822198
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of skin cancers during 5-year follow-up after stopping antioxidant vitamins and mineral supplementation.
    Ezzedine K; Latreille J; Kesse-Guyot E; Galan P; Hercberg S; Guinot C; Malvy D
    Eur J Cancer; 2010 Dec; 46(18):3316-22. PubMed ID: 20605091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and histological studies on the problem of drug-induced arsenic tumors].
    Ehlers G
    Z Haut Geschlechtskr; 1968 Sep; 43(18):763-74. PubMed ID: 4886760
    [No Abstract]   [Full Text] [Related]  

  • 17. In Brief: Hydrochlorothiazide and skin cancer.
    Med Lett Drugs Ther; 2020 Nov; 62(1611):177. PubMed ID: 33429413
    [No Abstract]   [Full Text] [Related]  

  • 18. Azathioprine and risk of multiple keratinocyte cancers.
    Cho HG; Kuo KY; Xiao K; Batra P; Li S; Tang JY; Sarin KY
    J Am Acad Dermatol; 2018 Jan; 78(1):27-28.e1. PubMed ID: 28989107
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hydrochlorothiazide use and risk of skin cancers: A systematic review].
    Becquart O; Guillot B; Bourrain JL; Duflos C; Du-Thanh A
    Rev Med Interne; 2019 Sep; 40(9):617-622. PubMed ID: 31101331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antihypertensive drugs and risk of skin cancer.
    Schmidt SA; Schmidt M; Mehnert F; Lemeshow S; Sørensen HT
    J Eur Acad Dermatol Venereol; 2015 Aug; 29(8):1545-54. PubMed ID: 25640031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.